Atlas Trials

Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function

Clinical trial NCT05126329 · TERMINATED

Trial details

NCT number
NCT05126329
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Function Abnormal
Start date
2021-11-15
Primary completion
2022-05-16
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.